MedCity News
APRIL 1, 2025
Isomorphic Labs financing led the way for first quarter 2025 financings, but it comes amid headwinds for the biotech sector. Biotech financing activity has been slowing down, analysts say. The post An AI Biotech Hauls In $600M, Plus More Funding Highlights to Close 1Q 2025 appeared first on MedCity News.
PharmaVoice
APRIL 1, 2025
The lack of clear communication from the government could spark wide-ranging issues in pharma — from sowing confusion about clinical trial design to further eroding public trust.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
APRIL 1, 2025
A new partnership between TeamHealth and Array Behavioral Care aims to enhance mental health support in emergency departments. The post TeamHealth, Array Behavioral Care Partner to Advance Emergency Behavioral Health Treatment appeared first on MedCity News.
PharmaVoice
APRIL 1, 2025
Dr. Mikael Dolsten, Pfizer’s former chief scientific officer, is embarking on a journey of curiosity and interconnectedness in his post-Big Pharma career.
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
MedCity News
APRIL 1, 2025
The conditions the biopharma companies target include sepsis, antimicrobial resistance, and acute infectious conjunctivitis. The post Which Biopharma Startups Made the Cut for INVEST Pitch Perfect? appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
APRIL 1, 2025
Reduction in force (RIF) job losses have started in earnest at US federal agencies, including the FDA and CDC, according to media reports
PharmaTimes
APRIL 1, 2025
Collaboration expands AI-based risk profiling tools
pharmaphorum
APRIL 1, 2025
EVERSANA has joined the growing roster of companies partnering with Veeva on the development of GenAI applications for the life sciences industry
PharmaTech
APRIL 1, 2025
Over the course of the next five years, the bio/pharma industry is expected to see the patents of multiple blockbuster drugs expire, impacting some key industry players.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
pharmaphorum
APRIL 1, 2025
The UK has given a world-first approval to Rotop's RoTecPSMA, a new imaging agent for detecting lesions in men with prostate cancer
PharmaTech
APRIL 1, 2025
Pharmaceutical Technology spoke with Will Gordon, senior vice president of Product Management, ArisGlobal, about how the geopolitical instabilities might impact the bio/pharmaceutical industry.
pharmaphorum
APRIL 1, 2025
AstraZeneca has revealed phase 2b results with its oral PCSK9 inhibitor AZD0780 as it tries to narrow a lead held by MSD with its rival cholesterol drug
Pharmaceutical Technology
APRIL 1, 2025
Total deal value of innovator drug licensing agreements involving Chinese biopharma licensors has risen 66% to $41.5 billion in 2024.
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
Pharmacy Times
APRIL 1, 2025
The CDC reports 483 total cases across 20 states as of March 28, 2025.
PharmaTech
APRIL 1, 2025
Webinar Date/Time: Friday, April 18, 2025 at 11am EDT
Pharmaceutical Technology
APRIL 1, 2025
GlobalData predicts that tirzepatide is likely to be increasingly prescribed for broader cardiometabolic disease.
PharmaTech
APRIL 1, 2025
William Wainwright, business development manager at Iwata Label USA, discusses the practical security benefits of functional labels at INTERPHEX 2025.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
PharmExec
APRIL 1, 2025
In the SOUL trial, Rybelsus produced a 14% risk reduction of major adverse cardiovascular events in patients with type 2 diabetes and cardiovascular disease and/or chronic kidney disease.
PharmaTech
APRIL 1, 2025
The Omni ASCENT, officially launched at INTERPHEX 2025, is a next-generation off-site manufactured vertical utility solution aimed at optimizing the flexibility and efficiency of cleanrooms.
Pharmaceutical Technology
APRIL 1, 2025
Is 'nearshoring', the preference among pharma and biotech to move operations to the domestic markets versus outsourcing abroad, becoming the norm?
PharmExec
APRIL 1, 2025
The trial size adjustment, along with protocol modifications and the addition of higher-enrollment sites, is expected to facilitate completion of the NEPHRO CRRT study of Niyad in patients undergoing renal replacement therapy by the end of 2025.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
PharmaTech
APRIL 1, 2025
The company said the Stratyx 250 is the first bioreactor of its kind to offer biotech companies a combination of automation, remote process control, and flexibility.
Pharmaceutical Technology
APRIL 1, 2025
In 2025, the CNS market is forecast to surpass $80bn in sales for the first time since 2013, marking a significant turnaround.
PharmaTech
APRIL 1, 2025
With advanced manufacturing, BioPures BioClamp connector is manufactured to be 13% lighter than the previous model, resulting in a 26% reduction in carbon dioxide emissions across the full lifecycle of the product.
Pharmaceutical Technology
APRIL 1, 2025
BioVersys has announced the grant of key patent claims in China for the BV100 technology, the intravenous formulation of rifabutin.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharmaceutical Commerce
APRIL 1, 2025
In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Colin Banas, MD, DrFirsts chief medical officer, discusses the challenges that many Americans face regarding the affordability of GLP-1 drugs.
Pharmaceutical Technology
APRIL 1, 2025
Platform trials offer increased flexibility and reduced costs for sponsors and CROs in clinical studies.
Pharmaceutical Commerce
APRIL 1, 2025
The latest news for pharma industry insiders.
Expert insights. Personalized for you.
268 
Let's personalize your content